What the Hemostasis Staffing Crunch Is Changing About Analyzer Selection
Staffing shortages are prompting clinical labs to prioritize automation, standardization, and preanalytical safeguards when selecting hemostasis analyzers.
Latest Articles
Editor's Top Picks
How Labs Are Driving the Andes Hantavirus Outbreak Response
Laboratories are leveraging established diagnostic and surveillance tools to track the Andes hantavirus outbreak linked to a cruise ship, with experts noting no evidence of widespread community transmission or efficient airborne spread.
Be the First to Know What’s Next in the Lab
Every week, we dig into the biggest shifts, breakthroughs, and tech transforming clinical diagnostics. Straightforward, insightful, and always relevant.Critical Resources
Diagnostic Innovations
BillionToOne Launches Non-Invasive Prenatal Confirmation Test Using Fetal Cells
BillionToOne has launched Unity Confirm, a non-invasive prenatal test that isolates fetal cells from maternal blood to confirm high-risk screening results, addressing the gap between NIPT and invasive diagnostics.
Equipment & Supply Spotlight
Avant Genomics Raises $3M for Automated Liquid Biopsy Sample Preparation
Avant Genomics has secured over $3 million in funding to develop its Avant Source platform, which aims to automate liquid biopsy sample preparation and improve cell-free DNA recovery.
News, Know-How & Standards
Disease Detection & Understanding
FDA Clears AI-Based Risk Stratification Tool for Breast Cancer
The FDA has cleared ArteraAI Breast, an AI-based digital pathology tool that provides same-day risk stratification for early-stage, HR-positive, HER2-negative invasive breast cancer.
